- Nachrichtendetail
-
26.04.2024 14:21:38 - dpa-AFX: *CHMP BACKS J&J'S RYBREVANT COMBO FOR FIRST-LINE NSCLC WITH EGFR EXON 20 MUTATION
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 149,910 | 10.05.24 03:00:06 | +0,060 | +0,04% | 149,720 | 150,050 | 150,000 | 149,910 |
